Roivant Sciences
Reinventing the discovery, development, and commercialization of new medicines
- Headquarters
- New York, New York
- Employees
- 201–500
- Founded
- 2014
- Business Model
- B2B
- Website
- roivant.com
- Total Funding
- $200.0M
- Valuation
- $7.0BNov 2018
- Last Round
- $200.0M Venture RoundNov 2018
- Rounds
- 1
About
Roivant Sciences is a biotech holding company that aims to improve health by rapidly delivering innovative medicines and technologies to patients. It builds agile, focused companies called Vants across multiple therapeutic areas.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Nov 2018
Investors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company
Specialty pharmaceutical company
Food technology company creating plant-based meat and dairy products that replicate the taste and...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.